Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-8-1
|
pubmed:abstractText |
The pharmacokinetics and clinical efficacy of a once-daily sustained-release formulation of naproxen (sodium salt) have been compared with those of conventional-release agents. In a single dose pharmacokinetic study, the rate of absorption of the sustained-release preparation was less than that of a conventional-release preparation but the extent of absorption was the same. As is the case with conventional-release naproxen, food decreased the rate but not the extent of absorption of the sustained-release formulation. On multiple dose administration for 7 days, the AUC and average concentrations of the sustained release preparation (1 g daily) were the same as those for conventional release preparations of naproxen sodium (250 mg four times daily) and naproxen free acid (500 mg daily). The conventional-release sodium salt was absorbed more quickly with no differences in bioavailability. A double-blind clinical comparison in patients with osteoarthritis showed the sustained-release preparation (1 g daily) to be equivalent in efficacy to conventional naproxen capsules (500 mg twice daily) but to have a significantly lower incidence of gastrointestinal side-effects. The results suggest that sustained-release naproxen sodium has potential for use as a once-daily treatment for inflammatory disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
383-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2661242-Adolescent,
pubmed-meshheading:2661242-Adult,
pubmed-meshheading:2661242-Aged,
pubmed-meshheading:2661242-Aged, 80 and over,
pubmed-meshheading:2661242-Clinical Trials as Topic,
pubmed-meshheading:2661242-Delayed-Action Preparations,
pubmed-meshheading:2661242-Double-Blind Method,
pubmed-meshheading:2661242-Humans,
pubmed-meshheading:2661242-Male,
pubmed-meshheading:2661242-Middle Aged,
pubmed-meshheading:2661242-Naproxen,
pubmed-meshheading:2661242-Osteoarthritis,
pubmed-meshheading:2661242-Pain,
pubmed-meshheading:2661242-Random Allocation
|
pubmed:year |
1989
|
pubmed:articleTitle |
Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen.
|
pubmed:affiliation |
Institute of Biopharmaceutics, Athlone, Ireland.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|